Zabofloxacin

DB12479InvestigationalSmall molecule

Zabofloxacin has been used in trials studying the treatment of Community Acquired Pneumonia and Chronic Obstructive Pulmonary Disease.

Chemical structure of Zabofloxacin
Formula / weight
C19H20FN5O4 · 401.398 g/mol (avg)

Resolves to

Compound
UNIILV66BA6V2GCAS219680-11-2PubChem9952872
Structure
InChIKeyZNPOCLHDJCAZAH-UHFFFAOYSA-NSMILESCON=C1CN(CC11CNC1)C1=C(F)C=C2C(=O)C(=CN(C3CC3)C2=N1)C(O)=O
Targets
P20831gyrAP0A0K8gyrB

What you can answer from here — as of February 04, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Zabofloxacin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In